News Releases

June 3, 2019
Urovant Sciences to Present at Annual Roivant Pipeline Day
IRVINE, Calif. & BASEL, Switzerland --(BUSINESS WIRE)--Jun. 3, 2019-- Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for urologic conditions, today announced Chief Executive Officer Keith A.
Additional Formats
Displaying 1 - 10 of 17